PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29802821-0	2018	microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.	Doxorubicin	27-37	microRNA 1295a	Homo sapiens	0-15	
29802821-0	2018	microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.	Doxorubicin	27-37	SRY-box transcription factor 2	Homo sapiens	79-83	
29802821-3	2018	microRNA-129-5p (miR-129-5p) has been considered a tumor-suppressive miRNA in several cancers, but its potential role in Adriamycin resistance in breast cancer has not been fully elucidate.	Doxorubicin	121-131	microRNA 1295a	Homo sapiens	0-15	
29802821-3	2018	microRNA-129-5p (miR-129-5p) has been considered a tumor-suppressive miRNA in several cancers, but its potential role in Adriamycin resistance in breast cancer has not been fully elucidate.	Doxorubicin	121-131	microRNA 1295a	Homo sapiens	17-27	
29802821-4	2018	By qRT-PCR assay, we revealed that the expression of miR-129-5p was significantly decreased in breast cancer tissues and Adriamycin-resistant breast cancer cells (MDA-MB-231/ADR, MCF-7/ADR).	Doxorubicin	121-131	microRNA 1295a	Homo sapiens	53-63	
29802821-5	2018	CCK-8, colony formation, wound healing, Transwell invasion, and flow cytometric profiles were examined to determine the influence of miR-129-5p on Adriamycin-resistant breast cancer in vitro.	Doxorubicin	147-157	microRNA 1295a	Homo sapiens	133-143	
29802821-6	2018	The upregulation of miR-129-5p decreased the IC50 concentration of Adriamycin and invasion and promoted the apoptosis of MDA-MB-231/ADR cells in the presence of Adriamycin, whereas the upregulation of Sex-Determining Region Y-Box 2 (SOX2) reversed these effects.	Doxorubicin	67-77	microRNA 1295a	Homo sapiens	20-30	
29802821-6	2018	The upregulation of miR-129-5p decreased the IC50 concentration of Adriamycin and invasion and promoted the apoptosis of MDA-MB-231/ADR cells in the presence of Adriamycin, whereas the upregulation of Sex-Determining Region Y-Box 2 (SOX2) reversed these effects.	Doxorubicin	161-171	microRNA 1295a	Homo sapiens	20-30	
29802821-8	2018	Collectively, it was suggested that miR-129-5p suppresses Adriamycin resistance in breast cancer by directly targeting SOX2.	Doxorubicin	58-68	microRNA 1295a	Homo sapiens	36-46	
29802821-8	2018	Collectively, it was suggested that miR-129-5p suppresses Adriamycin resistance in breast cancer by directly targeting SOX2.	Doxorubicin	58-68	SRY-box transcription factor 2	Homo sapiens	119-123